Decision: Favourable

Study Title:

A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome – RECONNECT

  • NREC Code:


  • Decision:


  • Meeting Date:


  • Study Type:

    CT application

  • Principal Investigator:

    Professor Louise Gallagher

  • PI Institution:

    St James's Hospital

  • Sponsor:

    Zynerba Pharmaceuticals, Inc

Scroll to Top
Skip to content